Navigation Links
CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
Date:7/31/2008

le to the Company, the Company may not have sufficient resources to pay punitive damages (which are not covered by insurance) or other liabilities in excess of available insurance, the Company may be unable to obtain sufficient financing to fully pursue its strategic plan and future healthcare policies, healthcare reimbursement methods, and healthcare reimbursement policies may affect the availability, amount, and timing of the Company's revenues. These risks and uncertainties include the risk factors detailed in CryoLife's Securities and Exchange Commission filings, including CryoLife's Form 10-K filing for the year ended December 31, 2007, its most recent Form 10-Q, and the Company's other SEC filings. The Company does not undertake to update its forward-looking statements.

Media Contacts:

D. Ashley Lee Katie Brazel

Executive Vice President, Fleishman Hillard

Chief Financial Officer and Phone: 404-739-0150

Chief Operating Officer

Phone: 770-419-3355

CRYOLIFE, INC. AND SUBSIDIARIES

Financial Highlights

(In thousands, except per share data)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

(Unaudited) (Unaudited)

Revenues:

Preservation services $13,725 $11,711 $27,149 $24,672

Products 13,280 11,156 25,260 22,551

Other 150 144 314 312

Total revenues 27,155 23,011 52,723 47,535

Costs and expenses:

Preservation services

(including write-downs of

$307
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
2. WuXi PharmaTech Schedules 2007 Second Quarter Earnings Release on Thursday, September 6, 2007
3. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
4. PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
7. Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, October 25, 2007
8. Replidyne to Announce Third Quarter 2007 Earnings
9. Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007
10. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
11. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., N.Y., Nov. 19 Dr. Mate Hidvegi, ...esponds to a press release issued on November 17 b...ny for making false and self-serving statements ab..., Dr. Hidvegi stated from his office in Budapest,...ch on Avemar does not apply to AveULTRA, www.ave...
(Date:11/19/2009)...UNSTER, Germany, November 19 MONIT... November 16th, 2009 Flibanserin in the,indication... Parkinson,s,disease for orphan drug status design...evodopa-induced dyskinesia is a complication of th... serious burden to some of those,affected, since i...
(Date:11/19/2009)...VIENNA, Austria, November 19 AFFiR...n one product candidate at an unexpectedly early,s... planned to enter into,Phase II clinical trial ear...ly follows the completion of two Phase I trials wi... its fast decision on the first interim,analysis o...
(Date:11/18/2009)...en,s University Belfast are developing new sensors... will help in the fight against the threat of terr...l pads to ,swipe, an individual or crime scene to ...ng instrument that can detect the presence of chem...er decisions to be made in response to terrorist t...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
...ion Coagulation Monitor Offers Both Built-in ...ontrols, INDIANAPOLIS, Oct. 29 Roche Diagnostics...uilt-in controls and optional, external,liquid con...agulation,ensure accurate PT/INR (clotting time) t...cation. The handheld, battery-powered CoaguChek X...
...CORONA, Calif., Oct. 29 /PRNewswire-FirstCall/,-- ...ticals, Inc. announced,today that under a supply a..., Inc., Watson has launched Tilia(TM) Fe (norethin...nd ferrous fumarate tablets), the generic,version ...R) Fe. Under the terms of the agreement, Warner C...
...Tapestry,Pharmaceuticals, Inc. (Nasdaq: TPPH ) an...on Monday, November 5, 2007 at 12:00 p.m. Eastern ...any,s third quarter 2007,financial results and pro...ess release regarding its second quarter financial...call. To participate in the conference call, plea...
Other Biology Technology:Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 2Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 3Roche Diagnostics Launches CoaguChek XS Plus System to Provide New PT/INR Point-of-Care Solution for Non-Waived Anticoagulation Services 4Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 2Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 3Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 4Tapestry to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results 2
(Date:11/19/2009)... NIH Director,s T-R01 Award , Speedier Lab Testin... Jaffrey, associate professor of pharmacology at W...esearchers to win a prestigious NIH Director,s Tra... of Health. Dr. Jaffrey and his colleagues are dev...s that may some day speed up lab testing by instan...
(Date:11/19/2009)...e professor in the Fischell Department of Bioengin...oscience Research and Technology Review Day with a...one and other types of tissue for implantation. ,...resented in an eight minute pitch by faculty membe...Fair, held November 12 at the University of Maryla...
(Date:11/19/2009)... have shown how an experimental drug might restore...uries by preventing short circuits caused when tin..., The chemical compound also might be developed ... nerves usually are not severed in a common type o...s, the drug offers hope as a possible treatment, s...
Breaking Biology News(10 mins):Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Drug studied as possible treatment for spinal injuries 2Drug studied as possible treatment for spinal injuries 3Jefferson Radiology Acquires Two Medical Imaging Center Offices 6143 1Jefferson Radiology Acquires Two Medical Imaging Center Offices 6143 2Alliance Seating 26amp 3B Mobility Launches Its ATP Development Program 6140 1Alliance Seating 26amp 3B Mobility Launches Its ATP Development Program 6140 2Over 2 200 veterans died in 2008 due to lack of health insurance 61079 1Over 2 200 veterans died in 2008 due to lack of health insurance 61079 2
... experiments with mice have found evidence that th...s in the eye essential for healthy vision. , The f...tal for eyesight called the retinal pigment epithe...archers writing in a recent issue of Investigative...a vital role in our visual health by forming the o...
...sity of Bristol has found a potential new treatmen.... Their work is reported in Nature Medicine. , The...shown that one particular antibiotic ? fosfomycin ...ineffective in laboratory conditions. , Because i...as never been considered for the treatment of list...
...e kilometers worldwide--about the area of Denmark....support few nonaquatic vertebrate species, but the...n of species and subspecies that are endemic (foun...ies, which seem to be largely restricted to North ...n a harsh environment in which seed abundance is l...
Other Biology News:Bone marrow may restore cells lost in vision diseases 2Bone marrow may restore cells lost in vision diseases 3Species unique to tidal marshes face threats 2
LS Columns from Miltenyi Biotec
Corning Erlenmeyer Flask, Pc, 250 ml, Plug Seal Cap, Sterile from Sigma-Aldrich
...reedom EVO384R are fast multi-channel pipetting pl...three different sizes, with a multi-channel head a...cant time saving, with true parallel processing of...th the Freedom EVOware program. Each of these ro...
...reedom EVO384R are fast multi-channel pipetting pl...three different sizes, with a multi-channel head a...cant time saving, with true parallel processing of...th the Freedom EVOware program. Each of these ro...
Biology Products: